Showing results (1461-1470 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 1, 1984
Macromolecular DNA-damage in murine and human leukemic and lymphoid cells after in vitro exposure to ASTA Z 7557 (INN mafosfamide)R Osieka, R Pannenbäcker, C G Schmidt
Investigational New Drugs|January 1, 1984
Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in miceM R Nowrousian, C G Schmidt
Investigational New Drugs|December 31, 2009
Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancerBinbing Ling, Lifeng Chen, Jane Alcorn, et al.
Investigational New Drugs|January 19, 2010
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumorsJoleen Hubbard, Charles Erlichman, David O Toft, et al.
Investigational New Drugs|January 19, 2010
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanomaEvan M Hersh, Steven J O'Day, John Powderly, et al.
Investigational New Drugs|December 22, 2009
A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastropheOliver Riesterer, Fumihiko Matsumoto, Li Wang, et al.
Investigational New Drugs|November 1, 1993
Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkeyS L Berg, F M Balis, K S Godwin, et al.
Investigational New Drugs|November 1, 1993
Effects of diflubenzuron and clanfenur on mouse bone marrow cellsV K Jenkins, H S Juneja, K Ives, et al.
Investigational New Drugs|November 1, 1993
Phase I pharmacokinetic study of DUP-937, a new anthrapyrazoleK Bélanger, J Jolivet, J Maroun, et al.
Investigational New Drugs|November 1, 1993
A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group studyT R Jenkins, C Tangen, J S Macdonald, et al.
Pageof 372